Report Categories Report Categories

Report Categories

industry Category

All

Total: 17 records, 2 pages

HuiJianTou lanJianTou

Global Rabeprazole Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Rabeprazole

According to our (Global Info Research) latest study, the global Rabeprazole market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Rabeprazole Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Rabeprazole Drug

According to our (Global Info Research) latest study, the global Rabeprazole Drug market size was valued at USD 221.2 million in 2023 and is forecast to a readjusted size of USD 278.6 million by 2030 with a CAGR of 3.3% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Rabeprazole Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Rabeprazole Sodium

According to our (Global Info Research) latest study, the global Rabeprazole Sodium market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Rabeprazole Sodium API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 15 Jan 2024

date Chemical & Material

new_biaoQian Rabeprazole Sodium API

According to our (Global Info Research) latest study, the global Rabeprazole Sodium API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Rabeprazole Sodium Enteric-Coated Tablets Supply, Demand and Key Producers, 2024-2030

date 02 Mar 2024

date Pharma & Healthcare

new_biaoQian Rabeprazole Sodium Enteric-Coated Tablets

The global Rabeprazole Sodium Enteric-Coated Tablets market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Rabeprazole Sodium Enteric-Coated Capsules Supply, Demand and Key Producers, 2024-2030

date 02 Mar 2024

date Pharma & Healthcare

new_biaoQian Rabeprazole Sodium Enteric-Coated Capsules

The global Rabeprazole Sodium Enteric-Coated Capsules market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Rabeprazole Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 05 Jan 2023

date Pharma & Healthcare

new_biaoQian Rabeprazole

Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion.

USD3480.00

Add To Cart

Add To Cart

Global Rabeprazole Drug Supply, Demand and Key Producers, 2023-2029

date 24 Feb 2023

date Pharma & Healthcare

new_biaoQian Rabeprazole Drug

Rabeprazole is a proton pump inhibitor that suppresses gastric acid production in the stomach. It has several medical uses: the management of conditions that involve excess gastric acid production (e.g. Zollinger–Ellison syndrome), conditions that are worsened by gastric acid (e.g. ulcerations of the gastrointestinal tract), and conditions involving prolonged exposure to gastric acid (e.g. symptomatic gastroesophageal reflux disease).

USD4480.00

Add To Cart

Add To Cart

Global Rabeprazole Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 07 Jan 2023

date Pharma & Healthcare

new_biaoQian Rabeprazole Drug

Rabeprazole is a proton pump inhibitor that suppresses gastric acid production in the stomach. It has several medical uses: the management of conditions that involve excess gastric acid production (e.g. Zollinger–Ellison syndrome), conditions that are worsened by gastric acid (e.g. ulcerations of the gastrointestinal tract), and conditions involving prolonged exposure to gastric acid (e.g. symptomatic gastroesophageal reflux disease).

USD3480.00

Add To Cart

Add To Cart

Global Rabeprazole Sodium Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Feb 2023

date Pharma & Healthcare

new_biaoQian Rabeprazole Sodium

Rabeprazole Sodium is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori bacterial infections in the stomach.

USD3480.00

Add To Cart

Add To Cart

Go To Page

Confirm

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Rabeprazole

According to our (Global Info Research) latest study, the global Rabeprazole market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Rabeprazole Drug

According to our (Global Info Research) latest study, the global Rabeprazole Drug market size was valued at USD 221.2 million in 2023 and is forecast to a readjusted size of USD 278.6 million by 2030 with a CAGR of 3.3% during review period.

USD3480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Rabeprazole Sodium

According to our (Global Info Research) latest study, the global Rabeprazole Sodium market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 15 Jan 2024

industry Chemical & Material

new_biaoQian Rabeprazole Sodium API

According to our (Global Info Research) latest study, the global Rabeprazole Sodium API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 02 Mar 2024

industry Pharma & Healthcare

new_biaoQian Rabeprazole Sodium Enteric-Coated Tablets

The global Rabeprazole Sodium Enteric-Coated Tablets market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Mar 2024

industry Pharma & Healthcare

new_biaoQian Rabeprazole Sodium Enteric-Coated Capsules

The global Rabeprazole Sodium Enteric-Coated Capsules market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 05 Jan 2023

industry Pharma & Healthcare

new_biaoQian Rabeprazole

Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion.

USD3480.00

addToCart

Add To Cart

industry 24 Feb 2023

industry Pharma & Healthcare

new_biaoQian Rabeprazole Drug

Rabeprazole is a proton pump inhibitor that suppresses gastric acid production in the stomach. It has several medical uses: the management of conditions that involve excess gastric acid production (e.g. Zollinger–Ellison syndrome), conditions that are worsened by gastric acid (e.g. ulcerations of the gastrointestinal tract), and conditions involving prolonged exposure to gastric acid (e.g. symptomatic gastroesophageal reflux disease).

USD4480.00

addToCart

Add To Cart

industry 07 Jan 2023

industry Pharma & Healthcare

new_biaoQian Rabeprazole Drug

Rabeprazole is a proton pump inhibitor that suppresses gastric acid production in the stomach. It has several medical uses: the management of conditions that involve excess gastric acid production (e.g. Zollinger–Ellison syndrome), conditions that are worsened by gastric acid (e.g. ulcerations of the gastrointestinal tract), and conditions involving prolonged exposure to gastric acid (e.g. symptomatic gastroesophageal reflux disease).

USD3480.00

addToCart

Add To Cart

industry 10 Feb 2023

industry Pharma & Healthcare

new_biaoQian Rabeprazole Sodium

Rabeprazole Sodium is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori bacterial infections in the stomach.

USD3480.00

addToCart

Add To Cart

Go To Page

Confirm